Stryker Corporation (SYK): Rep. Jared Moskowitz (FL23) disclosed a purchase $1K–$15K
Rep. Jared Moskowitz (FL23) disclosed a purchase of Stryker Corporation in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 26 days
- Disclosure lag
- Traded
- Jan 15, 2025
- Disclosed
- Feb 10, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 15, 2024InsiderOfficer sold ~$201K of SYK shares in the open market
- Jan 15, 2025 · this disclosureCongressDisclosed purchase of SYK — reported range $1,001 - $15,000
What came next
- Jan 15, 2025CongressDisclosed purchase of SYK — reported range $1,001 - $15,000
- Jan 31, 2025Insider · 1 personInsiders: 7 sales (~$92.7M)
- Feb 18, 2025InsiderDirector sold ~$942K of SYK shares in the open market
- Feb 25, 2025FDARecall: Otopore Cylinder outer ear wound dressing, Firm Catalog Number 5400-020-000 and Forte Catalog Number 5400-020-000TL
- Feb 25, 2025FDARecall: Nasopore FD fragmentable nasal dressing, Catalog Numbers 5400-020-108 and 5400-020-108ITL
- Feb 25, 2025FDARecall: Otopore Square outer ear wound dressing, Firm Catalog Number 5400-020-100 and Forte Catalog Number 5400-020-100ITL
- Feb 26, 2025CongressDisclosed partial sale of SYK — reported range $15,001 - $50,000
- Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 14/16mm; Catalog 48019120.
- Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 10/12mm; Catalog 48019100.
- Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 18/20mm; Catalog 48019130.
- Feb 28, 2025FDARecall: Monterey AL Implant Inserter; 22mm; Catalog 48019140.
- Mar 11, 2025FDAFDA device clearance: iBur 3.0mm Diamond Match Head, Distal Bend (8431-107-030D); iBur 3.0mm Precision Round, Distal Bend (8431-009-030); iBur 4.0mm Precision Round, Distal Bend (84…
- Mar 13, 2025CongressDisclosed partial sale of SYK — reported range $50,001 - $100,000
- Mar 21, 2025FDAFDA device clearance: Excelsior XT-27 Microcatheter, Excelsior XT-27 Flex Microcatheter, Excelsior XT-27 Pre-Shaped Microcatheter, Excelsior XT-27 Flex Pre-Shaped Microcatheter
- Mar 21, 2025FDAFDA device clearance: Consolidated Operating Room Equipment (CORE) 2 Console
- Mar 24, 2025FDAFDA device clearance: Sonopet iQ Ultrasonic Aspirator System (5500-050-000)
- Mar 28, 2025FDARecall: Guide Wire with Ruler Tube 3x800 mm DIA; Catalog number/REF: 2351-3080S;
- Mar 28, 2025FDARecall: Guide Wire with Ruler Tube 3x1000 mm DIA; Catalog number/REF: 2351-3100S;
- Apr 7, 2025Congress · 2 peopleMembers of Congress: 1 purchase, 1 sale
- Apr 8, 2025Congress · 1 personMembers of Congress: 2 sales
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Stryker Corporation
For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.
Other recent filings by Rep. Jared Moskowitz (FL23)
- House Clerk periodic transaction report at Applied Materials (AMAT)Aug 27, 2026
- House Clerk periodic transaction report at Steris (STE)Aug 27, 2026
- House Clerk periodic transaction report at W. W. Grainger (GWW)Aug 27, 2026
- House Clerk periodic transaction report at S&P Global (SPGI)Jul 26, 2026
- House Clerk periodic transaction report at Applied Materials (AMAT)Jul 26, 2026
The full history of Rep. Jared Moskowitz (FL23) is on the profile page.
How this filing works
Explore the data
Common questions
Which member of Congress traded Stryker Corporation (SYK) stock, and how much?
Rep. Jared Moskowitz (FL23) disclosed a purchase of Stryker Corporation in the $1K–$15K range. Reported range, not an exact amount, Dependent child account.
When did it happen, and when was it made public?
Traded: Jan 15, 2025. Disclosed: Feb 10, 2025. That is 26 days between the two dates.
Why is the amount a range and not an exact figure?
Members of Congress report each trade in a bracket set by law ($1,001 to $15,000, $15,001 to $50,000, and so on), never an exact amount. OQRO keeps the bracket as filed and does not estimate a figure inside it.
Where does this information come from?
From the House Clerk periodic transaction report, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Stryker Corporation recently?
For Stryker Corporation, OQRO holds 33 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 2 federal contract awards dated in the last 90 days. They are listed on the SYK page.
Does this mean SYK stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Stryker Corporation
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
- SEC Form 4Nov 9, 2026
Everything OQRO holds on this company is on its SYK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
